Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.900
-0.090 (-4.52%)
At close: Mar 31, 2025, 4:00 PM
2.450
+0.550 (28.95%)
After-hours: Mar 31, 2025, 7:59 PM EDT
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $262.74 million as of March 31, 2025. Its market cap has increased by 6.26% in one year.
Market Cap
262.74M
Enterprise Value
142.65M
1-Year Change
6.26%
Ranking
Category
Stock Price
$1.90
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $262.74M, a decrease of -39.65%. That is a compound annual growth rate of -11.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 262.74M | 31.69% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |